Causes and Base Rate of Lactic Acidosis
Lactic acidosis is primarily classified into Type A (inadequate tissue perfusion/oxygenation) and Type B (other causes), with metformin-associated lactic acidosis being rare at 2-9 cases per 100,000 patients per year. 1
Classification of Lactic Acidosis
Type A Lactic Acidosis (Tissue Hypoxia)
- Circulatory disorders including shock and cardiac failure leading to inadequate tissue perfusion 1, 2
- Severe infections and sepsis causing systemic hypoperfusion 1
- Pulmonary disorders resulting in hypoxemia 2
- Hemoglobin transfer disorders affecting oxygen delivery to tissues 2
Type B Lactic Acidosis (Non-Hypoxic)
- Medication-induced, particularly metformin in patients with renal impairment 1, 3
- Nucleoside reverse transcriptase inhibitors (NRTIs) in HIV treatment, especially stavudine and didanosine 4, 1
- Liver disease impairing lactate metabolism 2
- D-lactic acidosis in patients with short bowel syndrome and preserved colon 1
- Malignancies causing increased glycolysis 2
- Thiamine deficiency affecting pyruvate dehydrogenase function 2
- Uncoupling of oxidative phosphorylation 2
Base Rate and Epidemiology
- Lactic acidosis is the most common form of metabolic acidosis 5
- Metformin-associated lactic acidosis occurs at a rate of 2-9 cases per 100,000 patients per year 1
- Incidence is higher in patients with renal impairment, with eGFR <30 mL/min/1.73m² 4, 3
- Lactic acidosis from metformin is exceedingly rare even in patients with GFR 30-60 mL/min/1.73m² 4
- In a study of patients with type 2 diabetes and COVID-19, metformin use was associated with increased incidence of lactic acidosis (adjusted hazard ratio 4.46) 4
Diagnostic Criteria
- Blood lactate levels >2 mmol/L are considered elevated 1
- Levels >5 mmol/L are considered abnormal 1, 3
- Levels >10 mmol/L are considered serious/life-threatening 1
- Arterial pH <7.3 with increased anion gap (>16) 1
- Metformin-associated lactic acidosis is characterized by elevated blood lactate concentrations (>5 mmol/L), anion gap acidosis, and increased lactate:pyruvate ratio 3
Risk Factors
- Renal impairment (eGFR <45 mL/min/1.73m²) 4, 3
- Advanced age (>65 years) 1, 3
- Liver disease 4, 2
- Cardiac disease, including congestive heart failure 4, 3
- Hypoxic conditions 2
- Sepsis and severe infections 1, 6
- Concurrent use of medications that impair renal function or increase metformin accumulation 3
- Radiologic procedures with iodinated contrast in patients on metformin 3
- Alcohol abuse 4
Clinical Presentation
- Often presents with nonspecific symptoms including:
- Severe cases may present with hypotension and resistant bradyarrhythmias 3
- In metformin overdose, can present with euglycemic diabetic ketoacidosis 7
Management Principles
- Discontinuation of offending medications (metformin, NRTIs) 1, 3
- Treatment of underlying causes (infection, shock, hypoxia) 1, 2
- Supportive care in a hospital setting 3
- Hemodialysis for severe metformin-associated lactic acidosis (metformin is dialyzable with clearance up to 170 mL/min) 3
- Sodium bicarbonate administration is controversial and may increase lactate production 2
- Early identification and intervention is crucial for improving outcomes 6
Special Considerations
- Metformin should be discontinued at the time of or prior to iodinated contrast imaging procedures in patients with eGFR between 30-60 mL/min/1.73m² 3
- The incidence of lactic acidosis in HIV patients has decreased as newer antiretrovirals have replaced older NRTIs like didanosine, stavudine, and zidovudine 4
- Multiple causes of lactic acidosis may coexist in critically ill patients 8